PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C- Submission to the National Institute for Health and Clinical Excellence (NICE)
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.767
https://www.valueinhealthjournal.com/article/S1098-3015(12)02480-1/fulltext
Title :
PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C- Submission to the National Institute for Health and Clinical Excellence (NICE)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02480-1&doi=10.1016/j.jval.2012.08.767
First page :
A328
Section Title :
Gastrointestinal Disorders
Open access? :
No
Section Order :
278